Cargando…
A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748180/ https://www.ncbi.nlm.nih.gov/pubmed/35013100 http://dx.doi.org/10.1038/s41392-021-00821-y |
| _version_ | 1784630970535641088 |
|---|---|
| author | Zheng, Anqi Wu, Lili Ma, Renyi Han, Pu Huang, Baoying Qiao, Chengpeng Wang, Qihui Tan, Wenjie Gao, George F. Han, Pengcheng |
| author_facet | Zheng, Anqi Wu, Lili Ma, Renyi Han, Pu Huang, Baoying Qiao, Chengpeng Wang, Qihui Tan, Wenjie Gao, George F. Han, Pengcheng |
| author_sort | Zheng, Anqi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8748180 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87481802022-01-11 A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants Zheng, Anqi Wu, Lili Ma, Renyi Han, Pu Huang, Baoying Qiao, Chengpeng Wang, Qihui Tan, Wenjie Gao, George F. Han, Pengcheng Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-01-11 /pmc/articles/PMC8748180/ /pubmed/35013100 http://dx.doi.org/10.1038/s41392-021-00821-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Zheng, Anqi Wu, Lili Ma, Renyi Han, Pu Huang, Baoying Qiao, Chengpeng Wang, Qihui Tan, Wenjie Gao, George F. Han, Pengcheng A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants |
| title | A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants |
| title_full | A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants |
| title_fullStr | A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants |
| title_full_unstemmed | A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants |
| title_short | A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants |
| title_sort | binding-enhanced but enzymatic activity-eliminated human ace2 efficiently neutralizes sars-cov-2 variants |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748180/ https://www.ncbi.nlm.nih.gov/pubmed/35013100 http://dx.doi.org/10.1038/s41392-021-00821-y |
| work_keys_str_mv | AT zhenganqi abindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT wulili abindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT marenyi abindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT hanpu abindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT huangbaoying abindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT qiaochengpeng abindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT wangqihui abindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT tanwenjie abindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT gaogeorgef abindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT hanpengcheng abindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT zhenganqi bindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT wulili bindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT marenyi bindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT hanpu bindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT huangbaoying bindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT qiaochengpeng bindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT wangqihui bindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT tanwenjie bindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT gaogeorgef bindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants AT hanpengcheng bindingenhancedbutenzymaticactivityeliminatedhumanace2efficientlyneutralizessarscov2variants |